Ensayos clínicos

8.676 ensayos encontrados

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY4064809 Combined With a CDK4/6 Inhibitor and Endocrine Therapy in Adults With HR+, HER2-Advanced Breast Cancer With a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

INTERVENTIONALInicio: 22 de dic de 2025ID: NCT07174336

ReclutandoFase 2ClinicalTrials.gov

A Phase 1/Phase 2 Open-label Single Arm Study With Dose Escalation (Part A), and Dose Expansion (Part B) Parts to Evaluate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants 10 to 50 Years Old With Non-congenital Myotonic Dystrophy Type 1

INTERVENTIONALInicio: 23 de jul de 2025ID: NCT06844214

ReclutandoFase 3ClinicalTrials.gov

A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR)

INTERVENTIONALInicio: 28 de jun de 2024ID: NCT06331312

ReclutandoFase 3ClinicalTrials.gov

Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition

INTERVENTIONALInicio: 2 de jul de 2025ID: NCT07177352

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301

INTERVENTIONALInicio: 5 de jun de 2024ID: NCT06112314

ReclutandoClinicalTrials.gov

Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated & Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment With Nuwiq, Octanate or Wilate - Efficacy & Safety Observational Study-Protect-NOW

OBSERVATIONALInicio: 13 de feb de 2018ID: NCT03695978

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis

INTERVENTIONALInicio: 27 de dic de 2023ID: NCT06141486

ReclutandoFase 3ClinicalTrials.gov

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, PARALLEL GROUP STUDY TO INVESTIGATE INTERMITTENT PREVENTION OF MENSTRUAL MIGRAINE WITH RIMEGEPANT COMPARED WITH PLACEBO IN WOMEN PARTICIPANTS 18 TO 45 YEARS OF AGE

INTERVENTIONALInicio: 11 de mar de 2025ID: NCT06641466

ReclutandoFase 3ClinicalTrials.gov

An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis

INTERVENTIONALInicio: 3 de oct de 2019ID: NCT03955445

ReclutandoFase 2ClinicalTrials.gov

A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

INTERVENTIONALInicio: 22 de dic de 2016ID: NCT02960022

ReclutandoFase 3ClinicalTrials.gov

A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

INTERVENTIONALInicio: 3 de oct de 2025ID: NCT07196722

ReclutandoClinicalTrials.gov

Effect of Consumption of a Milk Product Designed for Lactating Women on Human Milk Composition and Nutritional Status of Iron and DHA in Infant Red Blood Cells.. Study in a Vulnerable Population.

INTERVENTIONALInicio: 1 de jun de 2024ID: NCT06319079

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis

INTERVENTIONALInicio: 31 de jul de 2025ID: NCT07044297

ReclutandoClinicalTrials.gov

Oncological Treatment During Pregnancy: Pharmacokinetics of Chemotherapy and Long Term Follow up of the Offspring

OBSERVATIONALInicio: 1 de ago de 2005ID: NCT00330447

ReclutandoFase 3ClinicalTrials.gov

Prospective, Multicenter, Randomized, Double-blind, Parallel Group, Placebo- Controlled, Efficacy and Safety Phase 3 Study of an Intravenous Human Plasma- Derived C1 Esterase Inhibitor (C1-INH) Concentrate in Participants With Congenital C1-INH Deficiency for the Treatment and Pre-procedure Prevention of Acute Hereditary Angioedema Attacks

INTERVENTIONALInicio: 30 de abr de 2024ID: NCT06361537

ReclutandoClinicalTrials.gov

LOWER: Lomitapide Observational Worldwide Evaluation Registry

OBSERVATIONALInicio: 18 de mar de 2014ID: NCT02135705

ReclutandoFase 2ClinicalTrials.gov

A Multicentre, Parallel-group, Phase II, Randomised, Double-blind, 4 Arm Study to Evaluate Efficacy and Safety of AZD1163 in Participants With Moderately-to-Severely Active Rheumatoid Arthritis (LaunchPAD-RA)

INTERVENTIONALInicio: 15 de dic de 2025ID: NCT07276581

ReclutandoFase 2ClinicalTrials.gov

A Phase 1B/2 Pan-Tumor, Open-Label Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

INTERVENTIONALInicio: 10 de abr de 2024ID: NCT06330064

ReclutandoClinicalTrials.gov

Identificación de la relación Entre Componentes de la Inmunidad Celular y Factores Inflamatorios y neuroendócrinos Como Determinantes Del pronóstico clínico en el síndrome Coronario Agudo

OBSERVATIONALInicio: 1 de ene de 2024ID: NCT06513611

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Ulcerative Colitis

INTERVENTIONALInicio: 11 de dic de 2024ID: NCT06588855